The human iris take part a central role in maintaining visual input to the retina while providing eye color and facial symmetry. Photophobia, a medical condition caused by exposure to light in patients with congenital or traumatic iris damage, causes bright light to affect the eyes, sensitivity and poor vision. Artificial iris lenses, which are artificially prepared and produced for the person, do not provide the dynamic effect of the natural iris, but provide aesthetics to the person. In this study, it is aimed to produce a new artificial iris that combines photochromic and polymer components to create an ophthalmic biomaterial that partially mimics the natural iris and is intended to have long-term implant stability in the eye, which could provide a new treatment option for congenital or trauma patients. To overcome a major limitation in available iris defect treatment options, rapid activation and turnaround times of less than 60 seconds have been preferred, along with synthetic and biocompatible lens materials. The artificial iris, which is planned to be produced locally, has been obtained by using smart materials that change their optical properties by absorbing the electromagnetic energy in UV rays, and coated with silicon-based solid and liquid polymers with high biocompatibility. The optical properties of the prototype irises were examined with the pre-coating mechanical test and the light transmittance test in a comparative way before and after the coating. According to these test results, it was evaluated whether the design study provided a significant reduction in light sensitivity.